121 results on '"Ficker, Joachim H."'
Search Results
2. Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study
3. Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
4. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
5. CAT score single item analysis in patients with COPD: Results from COSYCONET
6. Positive airway pressure telehealth models and long-term therapy termination: a healthcare database analysis.
7. Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD
8. Effect of a patient engagement tool on positive airway pressure adherence: analysis of a German healthcare provider database
9. Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium
10. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
11. Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report.
12. Trends der Lungenkrebsinzidenz nach histologischem Subtyp bei Männern und Frauen in Deutschland: Analyse von Krebsregisterdaten unter Einsatz von multipler Imputation
13. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial
14. Predictors of positive airway pressure therapy termination in the first year: analysis of big data from a German homecare provider
15. Telemedicine-based proactive patient management during positive airway pressure therapy: Impact on therapy termination rate
16. Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
17. Detection of cardiovascular risk from a photoplethysmographic signal using a matching pursuit algorithm
18. Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy.
19. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET.
20. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis.
21. Neue Methoden der nasalen Überdrucktherapie bei der Schlafapnoe
22. Arousals: Aktueller Stand, Klinische Bedeutung und offene Fragen
23. Adherence to Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea: Impact of Patient Education after a Longer Treatment Period
24. Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial.
25. Beyond the AHI–pulse wave analysis during sleep for recognition of cardiovascular risk in sleep apnea patients.
26. Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET.
27. Continuous Positive Airway Pressure Treatment Rapidly Improves Insulin Sensitivity in Patients with Obstructive Sleep Apnea Syndrome
28. Afatinib as first-line treatment in patients with EGFR -mutated non-small cell lung cancer in routine clinical practice.
29. Sensitivity of a simplified forced oscillation technique for detection of upper airway obstruction
30. Parasternale Vorwölbung bei einem Sportschützen
31. Effects of continuous positive airway pressure therapy on daytime and nighttime arterial blood pressure in patients with severe obstructive sleep apnea and endothelial dysfunction.
32. Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
33. Wenn CPAP nicht genutzt oder nicht vertragen wird – Vorschlag für eine standardisierte Terminologie.
34. Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort.
35. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
36. Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort.
37. Anhaltender Husten bei Muskeldystrophie
38. Mediastinalemphysem bei Trichterbrust
39. Beatmungspflichtige respiratorische Insuffizienz bei einem 20-jährigen Patienten
40. Rezidivierende gluteale Spritzenabszesse als Komplikation häufiger intramuskulärer Selbstinjektionen
41. Dyspnoe und abdominelle Schmerzen bei einer Patientin mit einem parakardialen Tumor Eine seltene Komplikation des Noonan-Syndroms: Eine seltene Komplikation des Noonan-Syndroms
42. Sweet-Syndrom als seltene kutane Komplikation eines Morbu Crohn
43. Rezidivierende “kalte Abszesse” mit Spontanperforation als seltene Verlaufsform einer abdominellen Tuberkulose
44. SOP Ambulant erworbene Pneumonie.
45. Unilaterales Asthma
46. Unilateral anhidrosis of the leg
47. Bridging Whole-Lung Lavage with Venovenous Extracorporeal Life Support for Pulmonary Alveolar Proteinosis.
48. Medical Treatment of COPD: An Analysis of Guideline-Adherent Prescribing in a Large National Cohort (COSYCONET).
49. Stentimplantation zur Behandlung der malignen oberen Einflussstauung.
50. Trends der Lungenkrebsinzidenz nach histologischem Subtyp bei Männern und Frauen in Deutschland.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.